There was no evidence of mutations in IDH2 and PLCG2, or other B‐cell lymphoma genes, including CARD11, CCND3, CREBBP, EP300, EZH2, FOXO1, MAP2K1, MEF2B, and MYD88. This evidence concerns the gene PLCG2 and B-cell non-Hodgkin lymphoma.